Valiant Laboratories IPO Guidance

Synopsys of the Review: 
The company is an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company, with steady and good profitability track-record.  The IPO size is also very small in mainboard category. Offer to HNI Investors and to the Retail investors is very small. Huge oversubscription expected, in spite of large number of IPOs. The offer price is quite reasonable(comparison with peer is also given in IPO page. Apply

About its business:

Valiant Laboratories is an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations.

Its manufacturing facility is located at Plot nos. L-13 and L-30, Tarapur Industrial Area, Boisar, Palghar
– 401506, in the state of Maharashtra, India which is spread over an aggregate parcel of land admeasuring about 2,000 sq. mts. with an aggregate annual total installed capacity of 9,000 MT per annum.

The company, through its wholly owned subsidiary, Valiant Advanced Sciences Private Limited intend to establish a greenfield project at Saykha Industrial Area, Bharuch, Gujarat, which shall be spread over an aggregate parcel of land admeasuring about 57,766 sq. mtrs. (“Proposed Facility”) which shall venture into manufacture of speciality chemicals such as ketene and diketene derivative products.

>>Go to Mainboard IPOs Section: Click
>>Go to SME IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com